Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Gains from Investment Securities (2019 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Gains from Investment Securities for 11 consecutive years, with $4.6 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 2197.0% to $4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Dec 2025, up 110.01% year-over-year, with the annual reading at $4.0 million for FY2025, 199.4% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $4.6 million at Madrigal Pharmaceuticals, up from $330000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $4.6 million in Q4 2025, with the low at $200000.0 in Q4 2024.
  • Average Gains from Investment Securities over 3 years is $1.6 million, with a median of $1.2 million recorded in 2024.
  • Peak annual rise in Gains from Investment Securities hit 2197.0% in 2025, while the deepest fall reached 71.75% in 2025.
  • Over 3 years, Gains from Investment Securities stood at $1.6 million in 2023, then tumbled by 87.71% to $200000.0 in 2024, then surged by 2197.0% to $4.6 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $4.6 million, $330000.0, and $200000.0 for Q4 2025, Q3 2025, and Q4 2024 respectively.